Bayer to acquire biotech AskBio for as much as $4 billion
Bayer is expanding in the cutting-edge field of gene and cell therapies at a time when its blockbuster drugs age and the firm’s crop-protection business reels from the pandemic’s impact on farm commodities after its purchase of Monsanto